LATEST

Study characterizes safety of pediatric psoriasis treatmentsA retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.
Psoriasis patient point of view
Psoriasis patient point of viewSurvey highlights the challenges of controlling psoriasis flares.
Impaired taste and smell may explain poor nutrition in psoriasis patientsPsoriasis has long been linked with poor nutrition, high body mass index and metabolic disorders. New research suggests a reduced sense of taste and smell, caused by inflammation, may explain why.
Genetic variation may explain why biologics help some patients, but fail othersPsoriasis patients carrying a specific gene experience a significantly better early response to ustekinumab, but are less likely to achieve high rates of response to anti-TNFs.
Cardiovascular disease in psoriasis may be due to a cardiosplenic axisThe spleen may have a role in driving the higher rate of cardiovascular disease seen in psoriasis patients through a spleen–atherosclerotic axis, suggests research presented at a meeting in London.
Diet and lifestyle factors may trigger psoriasisEnvironmental and lifestyle factors, such as certain foods and infections, may trigger onset of psoriasis and account for approximately 30% of the risk of the condition in people with a genetic preposition, research presented in London shows.
Isotretinoin may ameliorate depression symptomsPooled meta-analysis does not support association between isotretinoin treatment for acne and worsening of depression.
Less isotretinoin monitoring?The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
Daylight photodynamic therapy as effective as conventional therapy for actinic keratosis
Daylight photodynamic therapy as effective as conventional therapy for actinic keratosisConventional photodynamic therapy is highly effective for actinic keratoses, but daylight photodynamic therapy proves to be just as effective and more tolerable, a study shows.
Chest actinic keratoses responds to low-level ingenol mebutate topicalA lower level concentration of ingenol mebutate gel for the chest significantly reduces actinic keratosis lesion counts without severe side effects, a study shows.

Poll

View Results